New Easier-to-Use GLP-1 Pill Safe for the Heart, Study Says

(MedPage Today) -- Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven.
Among adults with type 2 diabetes and obesity or overweight at risk for increased cardiovascular...